Clinical trials: Chronic Periaortitis
Chronic Periaortitis, Intrabony Periodontal Defect
Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
Periodontitis is a major oral health problem which leads to the progressive destruction of periodontal ligament and alveolar bone with pocket formation, recession or both.
- Trial name
- NCT03009097
- Testing
- DFDBA, DFDBA with atorvastatin
- Volunteers
- 26 people
- Sponsor
- Kamineni Institute of Dental Sciences
Retroperitoneal Fibrosis
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Idiopathic retroperitoneal fibrosis (IRF) is a rare disease characterised by the presence of a retroperitoneal periaortic fibro-inflammatory tissue which may entrap the ureters and cause renal failure.
- Trial name
- NCT00440349
- Testing
- Tamoxifen, Prednisone
- Where
- Italy
- Volunteers
- 38 people
- Sponsor
- University of Parma
Idiopathic Retroperitoneal Fibrosis, Perianeurysmal Retroperitoneal Fibrosis
Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Chronic periaortitis is a clinico-pathological entity encompassing idiopathic retroperitoneal fibrosis and perianeurysmal retroperitoneal fibrosis.
- Conditions
- Idiopathic Retroperitoneal Fibrosis, Perianeurysmal Retroperitoneal Fibrosis, Chronic Periaortitis
- Trial name
- FIPREDEX (NCT01240850)
- Testing
- Methotrexate+Prednisone, Prednisone
- Where
- Italy
- Volunteers
- 200 people
- Sponsor
- University of Parma
Chronic Periaortitis, Tocilizumab Monotherapy
Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis
This is a prospective study to investigate the treatment response of Tocilizumab on patients with active chronic periaortitis (CP).
- Trial name
- NCT05133895
- Testing
- Tocilizumab monotherapy
- Where
- China
- Volunteers
- 12 people
- Sponsor
- Peking Union Medical College Hospital